Mary E. Rinella

机构：University of Illinois Chicago, University of Chicago · ORCID：0000-0003-0620-9705

发表论文 280 篇 · 总被引 50130 次 · h-index 71

代表论文

• Efruxifermin in Compensated Liver Cirrhosis Caused by MASH (2025 · New England Journal of Medicine · 被引 114)
• Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 21)
• Effects of Resmetirom on Metabolic‐Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon‐Like Peptide‐1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO ‐ NASH Trial (2025 · Alimentary Pharmacology & Therapeutics · 被引 20)
• The People-First Liver Charter (2025 · Nature Medicine · 被引 18)
• Awareness of metabolic dysfunction–associated steatotic liver disease (MASLD) in 4 major cities in the United States (2025 · Hepatology Communications · 被引 7)
• Aspirin Use and Mediterranean Diet Adherence as Factors Associated With Overall Mortality in Patients With MASLD in NHANES (2025 · Hepatology Research · 被引 4)